Specific intracellular retention of circSKA3 promotes colorectal cancer metastasis by attenuating ubiquitination and degradation of SLUG.
Jingwen DengShaoxia LiaoChaoyi ChenFengyan HanSiqin LeiXuan LaiKehong YeQizheng HanFang EChao LuMaode LaiFanlong LiuHonghe ZhangPublished in: Cell death & disease (2023)
Our previous study demonstrated that tumor-suppressor circular RNAs (circRNAs) can be specifically secreted outside of colorectal cancer (CRC) cells within exosomes to maintain tumor cell fitness. However, whether tumor-driving circRNAs can be specifically retained in cells to facilitate tumor progression remains unknown. In this study, circRNA-seq showed that circSKA3 was significantly upregulated in CRC tissues but downregulated in serum samples from CRC patients. In addition, circSKA3 promoted CRC progression in vitro and in vivo and was retained in CRC cells via a specific cellmotif element. Interestingly, the cellmotif element was also the site of interaction of circSKA3 with SLUG, which inhibited SLUG ubiquitination degradation and promoted CRC epithelial-mesenchymal transition (EMT). Moreover, FUS was identified as a key circularization regulator of circSKA3 that bound to the key element. Finally, we designed and synthesized specific antisense oligonucleotides (ASOs) targeting circularization and cellmotif elements, which repressed circSKA3 expression, abolished the SLUG-circSKA3 interaction, and further inhibited CRC EMT and metastasis in vitro and in vivo.
Keyphrases
- epithelial mesenchymal transition
- induced apoptosis
- signaling pathway
- cell cycle arrest
- transforming growth factor
- poor prognosis
- single cell
- stem cells
- endoplasmic reticulum stress
- gene expression
- newly diagnosed
- ejection fraction
- end stage renal disease
- genome wide
- body composition
- oxidative stress
- bone marrow
- cell proliferation
- prognostic factors
- rna seq
- drug delivery
- pi k akt
- cancer therapy
- peritoneal dialysis